Hsp90 inhibitors: a potential treatment for latent EBV infection?

Cell Cycle. 2010 May;9(9):1665-6. doi: 10.4161/cc.9.9.11594. Epub 2010 May 19.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antiviral Agents / therapeutic use
  • Benzoquinones / therapeutic use
  • Dipeptides / therapeutic use
  • Epstein-Barr Virus Infections / drug therapy*
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors*
  • HSP90 Heat-Shock Proteins / metabolism
  • Herpesvirus 4, Human*
  • Humans
  • Lactams, Macrocyclic / therapeutic use
  • Viral Proteins / antagonists & inhibitors
  • Viral Proteins / genetics
  • Viral Proteins / metabolism

Substances

  • Antiviral Agents
  • Benzoquinones
  • Dipeptides
  • HSP90 Heat-Shock Proteins
  • Lactams, Macrocyclic
  • Viral Proteins
  • tanespimycin
  • N-glycylalanine
  • geldanamycin